Berkeley Capital Partners’s Amgen AMGN Stock Holding History

Berkeley Capital Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,942	Closed	-$799K	–	107
2020 Q1	$799K	Buy	+3,942	New	+$861K	0.54%	35

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkeley Capital Partners's AMGN Position: Q2 2020 in Review

Berkeley Capital Partners sold out of Amgen (AMGN) in Q2 2020, closing a stake of 3,942 shares — an estimated $799K sold.

Berkeley Capital Partners first reported a position in AMGN in Q1 2020 and held it in 1 quarter. The position peaked at $799K in Q1 2020. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

Berkeley Capital Partners reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
Berkeley Capital Partners sold 3,942 Amgen shares in Q2 2020, an estimated $799K.
Berkeley Capital Partners first reported a position in Amgen in Q1 2020 and held it in 1 quarter.
Berkeley Capital Partners's Amgen position peaked at $799K in Q1 2020.
2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on Berkeley Capital Partners's 13F filing for Q2 2020, filed 30 Jul 2020.